Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-25 @ 8:22 AM
Study NCT ID:
NCT03961867
Status:
UNKNOWN
Last Update Posted:
2021-06-01
First Post:
2019-05-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma
Sponsor:
Sixth Affiliated Hospital, Sun Yat-sen University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SAHMO203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None